Monoamine Oxidase Inhibitors (MAOIs) Market Share, Size, Demand, Key Players by Forecast 2032
Monoamine oxidase inhibitors (MAOIs) are a class of drugs used primarily as antidepressants. They work by inhibiting the activity of the enzyme monoamine oxidase, which breaks down neurotransmitters such as serotonin, dopamine, and norepinephrine.
Get A Report Copy of this Market: https://wemarketresearch.com/r....eports/monoamine-oxi